Skip to main content

Table 1 Clinical sleep assessments, PSG parameters, and inflammatory markers of the PTSD group at baseline (T1) and one-year follow-up (T2)

From: Sleep characteristics and inflammatory markers in women with post-traumatic stress disorder

 

T1 (N = 57)

mean ± SD

T2 (N = 29)

mean ± SD

p

Clinical assessments

   

BDI

27.68 ± 12.55

11.65 ± 11.61

< 0.001

CAPS-5

42.44 ± 9.31

20.27 ± 18.30

< 0.001

Sleep assessments

   

PSQI

10 ± 3.55

6.81 ± 5.22

0.001

ISI

15.07 ± 6.08

7.73 ± 7.92

< 0.001

PSG parameters

   

TST

340.11 ± 62.51

336.30 ± 111.01

0.80

N3%

24.12 ± 7.14

21.88 ± 9.86

0.21

AI

10.61 ± 4.15

13.44 ± 8.48

0.06

Inflammatory markers

   

IL-1β

1.38 ± 1.10

1.88 ± 0.62

< 0.001

IL-6

1.75 ± 1.64

2.15 ± 1.56

0.32

TNF-α

6.81 ± 2.55

11.54 ± 5.20

< 0.001

CRP

0.29 ± 0.54

2.75 ± 1.62

< 0.001

  1. GEE model, p < 0.05
  2. BDI = Beck Depression Inventory; CAPS-5 = Clinician-Administered PTSD Scale; PSQI = Pittsburgh Sleep Quality Index; ISI = Insomnia Severity Index; TST = Total Sleep Time; N3% = N3 sleep percentage; AI = Arousal Index; IL1β = Interleukin1β; IL-6 = Interleukin 6; TNF-α = Tumor necrosis factor α; CRP = C-reactive protein; T1 = Baseline; T2 = One year